You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CML Predictive Study

Showing 1 - 25 of 4,883
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in France (Nilotinib)

Completed
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Angers, France
  • +9 more
Aug 17, 2022

Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Completed
  • Chronic Myeloid Leukemia
  • Stem Cell and Mutational Assay
  • Vancouver, British Columbia, Canada
    Leukemia BMT program of BC, Vancouver General Hospital, Hematolo
Apr 29, 2021

Chronic Myeloid Leukemia Trial in New York (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Mar 24, 2022

Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL

Active, not recruiting
  • Chronic Phase Chronic Myeloid Leukemia
    • Chicago, Illinois
    • +24 more
    May 24, 2021

    Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in

    Recruiting
    • Acute Biphenotypic Leukemia
    • +13 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

    Completed
    • Chronic Myeloid Leukemia
    • Stopping treatment with TKI
    • Brno, Czechia
    • +49 more
    Oct 29, 2021

    TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy

    Recruiting
    • Chronic Myeloid Leukemia
    • Pisa, Italy
    • +1 more
    Jan 4, 2022

    Concomitant Medications at CML Diagnosis

    Completed
    • Chronic Myeloid Leukemia
    • the prevalence of comorbid conditions
    • (no location specified)
    Sep 16, 2023

    Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    Aug 24, 2022

    Metabolic Alternation and Clinicohematological Characteristic in

    Not yet recruiting
    • CML, Chronic Phase
    • Tyrosine kinase inhibitor
    • (no location specified)
    Nov 6, 2023

    CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

    Recruiting
    • CML
    • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
    • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
      FUNDALEU
    Jun 29, 2023

    Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

    Not yet recruiting
    • Tyrosine Kinase Inhibitors
    • Chronic Myeloid Leukemia
    • treatment of TKI in CML
    • Poitiers, France
      Chu Poitiers
    Feb 21, 2023

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated

    Completed
    • Chronic Myeloid Leukaemia
    • Rionero in Vulture, Potenza, Italy
    • +32 more
    Oct 24, 2022

    According to Molecular Identification at Diagnosis

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Next Generation Sequencing (DNA and RNA)
    • (no location specified)
    Oct 28, 2022

    Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Boston, Massachusetts
    • +18 more
    Jan 19, 2023

    Chronic Phase-Chronic Myeloid Leukemia Trial in Madrid (Bosutinib 400 MG Monotherapy, Bosutinib 400 MG + Atezolizumab 840 MG in

    Recruiting
    • Chronic Phase-Chronic Myeloid Leukemia
    • Bosutinib 400 MG Monotherapy
    • Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection
    • Madrid, Spain
      Hospital Universitario Ramón y Cajal
    Mar 8, 2021

    CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

    Recruiting
    • CML, Chronic Phase
    • CML, Accelerated Phase
    • HS-10382(Part 1: Dose escalation)
    • HS-10382(Part 2: Dose expansion)
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jan 12, 2023

    "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

    Not yet recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Sohag, Egypt
        Sohag University Hospital
      Sep 14, 2022

      Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      Has Results
      • Leukemia
      • Birmingham, Alabama
      • +173 more
      Dec 1, 2022

      Leukemia,Myeloid, Chronic Trial in France (Blood and bone marrow sample)

      Not yet recruiting
      • Leukemia,Myeloid, Chronic
      • Blood and bone marrow sample
      • Annecy, France
      • +15 more
      Nov 10, 2023

      Asciminib RMP Study

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Asciminib
      • (no location specified)
      Jul 5, 2023

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022

        Landscape and Real-life Treatment Outcomes in Hungary: Analysis

        Completed
        • Chronic Myeloid Leukaemia
        • Budapest, Hungary
          Pfizer
        Dec 15, 2022